KP Tissue (KPT) Stock Price, News & Analysis

Company Overview

KP Tissue Inc., through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins. The company markets its products under the Cashmere, SpongeTowels, Scotties, Purex, Bonterra, Metro, White Swan, White Cloud, Embassy, Satinelle, and Chalet brand names, as well as under private labels. KP Tissue Inc. was incorporated in 2012 and is headquartered in Mississauga, Canada.

Key Stats

• Today's Range: C$8.12 to C$8.20
• 50-Day Range: C$8.06 to C$8.47
• 52-Week Range: C$7.99 to C$9.25
• Volume: 6,950 shs
• Average Volume: 18,387 shs
• Market Capitalization: C$81.16 million
• P/E Ratio: 13.57
• Dividend Yield: 8.85%
• Price Target: C$9.25
• Consensus Rating: Hold

KP Tissue Stock Analysis - MarketRank™

KP Tissue scored higher than 40% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.0 / 5
• Analyst Rating: Hold

Consensus Rating

KP Tissue has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings.

Amount of Analyst Coverage

KP Tissue has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of KP Tissue is 13.58, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 134.95.

Price to Earnings Ratio vs. Sector

The P/E ratio of KP Tissue is 13.58, which means that it is trading at a less expensive P/E ratio than the Consumer Defensive sector average P/E ratio of about 212.12.

Price to Earnings Growth Ratio

Due to a projected decrease in earnings for KP Tissue, their PEG ratio cannot be calculated.

Price to Book Value per Share Ratio

KP Tissue has a P/B Ratio of 1.13. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for KPT.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

KP Tissue is a leading dividend payer. It pays a dividend yield of 8.48%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

KP Tissue does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of KP Tissue is 120.00%. Payout ratios above 75% are not desirable because they may not be sustainable.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for KPT.

News and Social Media

• Score: 3.0 / 5
• News Sentiment: 0.42

News Sentiment

KP Tissue has a news sentiment score of 0.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.26 average news sentiment score of Consumer Defensive companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for KP Tissue this week, compared to 1 article on an average week.

Search Interest

1 people have searched for KPT on MarketBeat in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, KP Tissue insiders have sold 17,640.07% more of their company's stock than they have bought. Specifically, they have bought C$831.00 in company stock and sold C$147,420.00 in company stock.

Percentage Held by Insiders

Only 0.14% of the stock of KP Tissue is held by insiders.

Percentage Held by Institutions

Only 8.61% of the stock of KP Tissue is held by institutions.

KPT Stock Analysis - Frequently Asked Questions

How have KPT shares performed this year?

KP Tissue's stock was trading at C$9.02 at the beginning of 2024. Since then, KPT stock has decreased by 9.6% and is now trading at C$8.15.
View the best growth stocks for 2024 here.

How do I buy shares of KP Tissue?

Shares of KPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of KP Tissue own?

Based on aggregate information from My MarketBeat watchlists, some other companies that KP Tissue investors own include Constellation Software (CSU), Intact Financial (IFC), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Wheaton Precious Metals (WPM) and Vermilion Energy (VET).

Company Calendar

• Ex-Dividend for 10/15 Dividend: 9/27/2024
• Dividend Payable: 10/15/2024
• Today: 12/18/2024

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Consumer Defensive
• Industry: Household & Personal Products
• Sub-Industry: N/A
• Current Symbol: TSE:KPT
• CUSIP: N/A
• CIK: N/A
• Web: kptissueinc.com
• Phone: +1-905-8126900
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: C$9.25
• High Stock Price Target: C$10.00
• Low Stock Price Target: C$9.00
• Potential Upside/Downside: +12.9%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 3 Analysts

Profitability

• EPS (Most Recent Fiscal Year): C$0.60
• Trailing P/E Ratio: 13.65
• Forward P/E Ratio: 18.62
• P/E Growth: -0.88
• Net Income: C$6.05 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: 8.58%
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.03
• Quick Ratio: 1.23

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: C$7.20 per share
• Price / Book: 1.14

Miscellaneous

• Outstanding Shares: 9,970,000
• Free Float: N/A
• Market Cap: C$81.65 million
• Optionable: Not Optionable
• Beta: 0.37